The Adenovirus Vector Platform: Novel Insights into Rational Vector Design and Lessons Learned from the COVID-19 Vaccine
Viruses · 11.01.2023 · 15 (1) · 204
DOI: 10.3390/v15010204 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 11.01.2023. Verfasst von Erwan Sallard und 4 weiteren Autor:innen. Beteiligte Einrichtung: Virology and Microbiology, Center for Biomedical Education and Research (ZBAF), School of Medicine, Faculty of Health, Witten/Herdecke University, 58…. Hauptthemen laut MEDLINE: COVID-19, Vaccines. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DFG.
Abstract (Originalsprache)
The adenovirus vector platform remains one of the most efficient toolboxes for generation of transfer vehicles used in gene therapy and virotherapy to treat tumors, as well as vaccines to protect from infectious diseases. The adenovirus genome and capsids can be modified using highly efficient techniques, and vectors can be produced at high titers, which facilitates their rapid adaptation to current needs and disease applications. Over recent years, the adenovirus vector platform has been in the center of attention for vaccine development against the ongoing coronavirus SARS-CoV-2/COVID-19 pandemic. The worldwide deployment of these vaccines has greatly deepened the knowledge on virus-host interactions and highlighted the need to further improve the effectiveness and safety not only of adenovirus-based vaccines but also of gene therapy and oncolytic virotherapy vectors. Based on the current evidence, we discuss here how adenoviral vectors can be further improved by intelligent molecular design. This review covers the full spectrum of state-of-the-art strategies to avoid vector-induced side effects ranging from the vectorization of non-canonical adenovirus types to novel genome engineering techniques.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Virology and Microbiology, Center for Biomedical Education and Research (ZBAF), School of Medicine, Faculty of Health, Witten/Herdecke University, 58453 Witten, Germany.
- Laboratory of Experimental Pediatric Pneumology and Allergology, Center for Biomedical Education and Research, School of Life Sciences (ZBAF), Faculty of Health, Witten/Herdecke University, 58455 Witten, Germany.
ORCID-Profile: Erwan Sallard, Wenli Zhang, Katrin Schröer
Förderung
- DFG
Zitieren
APA
Sallard, E., Zhang, W., Aydin, M., Schröer, K., & Ehrhardt, A. (2023). The Adenovirus Vector Platform: Novel Insights into Rational Vector Design and Lessons Learned from the COVID-19 Vaccine. Viruses, 15(1), 204. https://doi.org/10.3390/v15010204
Vancouver
Sallard E, Zhang W, Aydin M, Schröer K, Ehrhardt A. The Adenovirus Vector Platform: Novel Insights into Rational Vector Design and Lessons Learned from the COVID-19 Vaccine. Viruses. 2023;15(1):204. doi:10.3390/v15010204
BibTeX
@article{Sallard2023,
author = {Sallard, Erwan and Zhang, Wenli and Aydin, Malik and Schröer, Katrin and Ehrhardt, Anja},
title = {The Adenovirus Vector Platform: Novel Insights into Rational Vector Design and Lessons Learned from the COVID-19 Vaccine},
journal = {Viruses},
year = {2023},
volume = {15},
number = {1},
pages = {204},
doi = {10.3390/v15010204}
}
EUVIMED